UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis

Biomedicine & pharmacotherapy, 2021-11, Vol.143, p.112115, Article 112115

2021

Volltextzugriff (PDF)

A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors

Frontiers in pharmacology, 2020-06, Vol.11, p.891

2020

Volltextzugriff (PDF)

DKVMN-KAPS: Dynamic Key-Value Memory Networks Knowledge Tracing With Students' Knowledge-Absorption Ability and Problem-Solving Ability

IEEE access, 2024, Vol.12, p.55146-55156

2024

Volltextzugriff (PDF)

Enhanced proliferation inhibition and apoptosis in glioma cells elicited by combination of irinotecan and imatinib

European journal of pharmacology, 2020-05, Vol.874, p.173022-173022, Article 173022

2020

Volltextzugriff (PDF)

HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport

Autophagy, 2018-12, Vol.14 (12), p.2155-2170

2018

Volltextzugriff (PDF)

Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis

Nature communications, 2023-05, Vol.14 (1), p.2756-2756, Article 2756

2023

Volltextzugriff (PDF)

s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide

Cell research, 2020-09, Vol.30 (9), p.779-793

2020

Volltextzugriff (PDF)

Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management

Expert review of clinical pharmacology, 2019-12, Vol.12 (12), p.1121-1127

2019

Volltextzugriff (PDF)

Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP Axis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (14), p.3995-4006

2018

Volltextzugriff (PDF)

Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair

PloS one, 2016-01, Vol.11 (1), p.e0146968

2016

Volltextzugriff (PDF)

Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation

Biomedicine & pharmacotherapy, 2021-12, Vol.144, p.112297, Article 112297

2021

Volltextzugriff (PDF)

Design, Synthesis and Evaluation of Indene Derivatives as Retinoic Acid Receptor α Agonists

Molecules (Basel, Switzerland), 2017-01, Vol.22 (1), p.32-32

2017

Volltextzugriff (PDF)

Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes

Toxicology and applied pharmacology, 2012-06, Vol.261 (3), p.280-291

2012

Volltextzugriff (PDF)

MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia

PloS one, 2013-06, Vol.8 (6), p.e66915

2013

Volltextzugriff (PDF)

The Combination of Gefitinib and Acetaminophen Exacerbates Hepatotoxicity via ROS-Mediated Apoptosis

Biomolecules & Therapeutics, 2024, 32(5), , pp.647-657

2024

Volltextzugriff (PDF)

Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL

Advanced science, 2023-09, Vol.10 (26), p.e2302002-n/a

2023

Volltextzugriff (PDF)

Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway

Toxicology and applied pharmacology, 2014-01, Vol.274 (2), p.319-327

2014

Volltextzugriff (PDF)

The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway

PloS one, 2011-11, Vol.6 (11), p.e27298

2011

Volltextzugriff (PDF)

The contribution of keratinocytes in capecitabine-stimulated Hand-Foot-Syndrome

Environmental toxicology and pharmacology, 2017-01, Vol.49, p.81-88

2017

Volltextzugriff (PDF)

Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress

Toxicology reports, 2016-01, Vol.3, p.78-86

2016

Volltextzugriff (PDF)

Inhibition of all-Trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells

Molecular carcinogenesis, 2011-01, Vol.50 (1), p.24-35

2011

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2014, Vol.10 (1), p.38-45

2014

Volltextzugriff (PDF)

Regulation of p53 stability as a therapeutic strategy for cancer

Biochemical pharmacology, 2021-03, Vol.185, p.114407, Article 114407

2021

Volltextzugriff (PDF)

Development and safety of PI3K inhibitors in cancer

Archives of toxicology, 2023-03, Vol.97 (3), p.635-650

2023

Volltextzugriff (PDF)

Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory

European journal of pharmacology, 2020-05, Vol.874, p.173026, Article 173026

2020

Volltextzugriff (PDF)

1 – 25 von 197

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis

A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors

DKVMN-KAPS: Dynamic Key-Value Memory Networks Knowledge Tracing With Students' Knowledge-Absorption Ability and Problem-Solving Ability

Enhanced proliferation inhibition and apoptosis in glioma cells elicited by combination of irinotecan and imatinib

HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport

Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis

s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide

Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management

Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP Axis

Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair

Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation

Design, Synthesis and Evaluation of Indene Derivatives as Retinoic Acid Receptor α Agonists

Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes

MEK/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia

The Combination of Gefitinib and Acetaminophen Exacerbates Hepatotoxicity via ROS-Mediated Apoptosis

Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL

Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway

The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway

The contribution of keratinocytes in capecitabine-stimulated Hand-Foot-Syndrome

Diosmetin protects against retinal injury via reduction of DNA damage and oxidative stress

Inhibition of all-Trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells

Design, synthesis and biological evaluation of novel non-peptide boronic acid derivatives as proteasome inhibitors

Regulation of p53 stability as a therapeutic strategy for cancer

Development and safety of PI3K inhibitors in cancer

Bisdemethoxycurcumin attenuates cisplatin-induced renal injury through anti-apoptosis, anti-oxidant and anti-inflammatory

Suchergebnisse filtern